Summary Type 11 pneumocytes and Clara cells, both epithelial cells that possess an active uptake system for polyamines, have been identified as possible precursor cells of at least some types of lung tumours. In this study we have investigated whether human pulmonary tumours exhibit putrescine uptake. Lung slices from both tumoral tissue and non-tumoral tissue, obtained from patients undergoing surgery for lung cancer, were incubated with radiolabelled putrescine at both 37C and 4'C. The accumulation of putrescine was evaluated by its apparent kinetic parameters, in the presence or absence of cystamine, and by autoradiography. The investigated tumoral tissue (six squamous carcinomas and five adenocarcinomas) did not show accumulation of putrescine above that attributable to simple diffusion, except for one adenocarcinoma. In this specimen autoradiography showed that the accumulation was not specifically associated with any particular cell type, but that practically every cell accumulated putrescine. We conclude that human pulmonary tumours do not accumulate polyamines in a manner similar to normal pulmonary epithelial cells.
Much more than any other major organ examined, normal lung tissue appears to accumulate polyamines via an active uptake system obeying Michaelis-Menten kinetics (Smith et al., 1982) . The propensity of normal lung tissue to accumulate polyamines was discovered after it had been found that the highly selective pneumotoxic herbicide paraquat is actively accumulated in lung tissue (Rose et al., 1974; Lock et al., 1976) and that this accumulation occurs because paraquat is 'mistaken' for the structurally somewhat similar polyamines (Smith, 1985) . The site of this uptake has been convincingly demonstrated to be essentially made up by the alveolar epithelium, i.e. type I and type II pneumocytes, as shown by autoradiography in both animal and human lungs (Nemery et al., 1987; Wyatt et al., 1988; Dinsdale et al., 1991; Hoet et al., 1993) . In addition, the non-ciliated bronchiolar (Clara) cells of the rat are also a site of uptake, at least in vitro (Nemery et al., 1987; Wyatt et al., 1988) , but this could neither be confirmed or denied for the human lung (Hoet et al., 1993) . Neither the alveolar cells nor the Clara cells are characterised by a high proliferation rate in the normal lung (Kauffman, 1980) , and thus the reasons for the substantial accumulation of polyamines by lung tissue are still unclear.
Given that a high polyamine uptake appears to be a specific feature of lung epithelial cells, it was logical to investigate whether some pulmonary epithelium-derived tumours would also exhibit a high polyamine uptake, irrespective of their proliferation rate.
Despite intensive study, the histogenetic origin of pulmonary tumours is still vague for most of the tumour types. On the basis of findings obtained in mice (Thaete and Malkinson, 1990; Malkinson, 1991) and in dog (Ten HaveOpbroek et al., 1990), adenocarcinomas have been considered to derive from type II pneumocytes. The origin of squamous cell carcinomas is still unclear, but there are suggestions that both Clara cells and type II pneumocytes could be implicated in human pulmonary epithelial tumours (Boyd and ReznikSchiiller, 1984; Devereux et al., 1986 strokes min-') at 37C (or at 4°C) (O'Neil et al., 1977) . The slices were incubated in KRPB containing putrescine (2.5 -80 jLM) and [1,4-'4C]putrescine (0.1 Ci per incubation flask) in the presence or absence of 50 gM cystamine. Putrescine uptake was determined as described previously (Hoet et al., 1993) , by measuring tissue-associated radioactivity.
The tissue-medium ratio of radioactivity was calculated as: (tissue radioactivity/0.7)/(medium radioactivity post incubation), with the factor 0.7 representing the 70% aqueous portion of the tissue containing free putrescine. Autoradiography Lung slices were incubated for 30 min at 37C in KRPB containing 2.5 JM putrescine and [1,4n-3H]putrescine (500 ILCi tLmol -').
At the end of the incubation, the slices were fixed in 6.5% glutaraldehyde in 0.1% cacodylate buffer (pH 7.4) and prepared for autoradiography, as previously described by Nemery et al. (1987) and Dinsdale et al. (1991) . Slices for light microscopy were embedded in EPON 812 resin and sections of 1 tLm thickness were mounted onto microscope slides. The slides were dipped at 40°C into an Ilford K2 nuclear emulsion (25%), dried, and kept at 4°C in the dark. After 50 days, the slides were developed (Ilford Phenisol, 15 min), fixed (1% acetic acid 2 min, 30% sodium thiosulphate) and stained (0.1% toluidine blue in 0.1% borax, 37TC, 9 min).
Analysis of data When intra-individual duplicate or triplicate determinations were available, an average value was taken. The apparent accumulation obtained at 37C was considered to represent the sum of the active uptake and the passive uptake by diffusion, with the latter being estimated from the incubations at 4°C. All weights are wet weights.
The maximum rate of uptake, Vmax (expressed in nmol gh-'), is achieved at infinite substrate concentration, and Km (expressed in jiM substrate) is the medium concentration at which the rate of uptake is half Vmax. The apparent kinetic parameters were calculated from a Hanes-Woolf plot (Engel, 198 1). Data from control and treated slices were compared by Student's t-test for paired data, or by analysis of variance with Duncan grouping, using the SAS/STAT package (6th version). The level of significance was set at P < 0.05.
Results

Putrescine accumulation
The macroscopically normal tissue accumulated putrescine, in an active manner, as described previously (Hoet et al., 1993) (Figure 1) . In the present group of subjects, this uptake In contrast, the accumulation of putrescine in tumoral tissue was linear with the medium concentration, both at 4°C and 37°C. When the data were grouped according to type of neoplasm, no differences in the rate of putrescine accumulation were found. Figure 2 shows that, in the tumoral tissue, the tissue-medium ratio of radioactivity was usually not higher than 1, indicating that the measured tissue radioactivity was essentially due to passive diffusion into the tissue. In one sample (sample 16) a higher ratio was observed.
Co-incubation of normal parenchyma with putrescine in the presence of 50 jIM cystamine, a known competitive inhibitor of putrescine uptake (Lewis et al., 1989) , resulted, as previously reported (Hoet et al., 1993) , in reduced accumulation of label (data not shown). In contrast, uptake by tumoral tissue was not affected by cystamine, except in samples from patient 16. In this sample the uptake was reduced, as in non-tumoral tissue, but levels were still higher than those attributable to passive diffusion. found in the tumoral tissue, except in sample 16 (Figure 3 ). This peculiar tumoral sample showed labelling all over the tissue section, with no concentration over any particular cell type.
Discussion
The pulmonary tumours studied did not show evidence of accumulation of putrescine, except in one case. The cellular accumulation of a compound may be considered as occurring via an active process when the accumulation: (i) occurs against a concentration gradient; (ii) is energy dependent; (iii) obeys saturation kinetics; and (iv) shows structure specificity. The pulmonary uptake of putrescine and other polyamines has been shown to fulfil these criteria when normal lung tissue or pulmonary epithelial cells from animals or humans were studied (Smith et al., 1982; Nemery et al., 1987; Hoet et al., 1993; . None of these requirements appeared to be met in the present study in which pulmonary tumoral tissue was examined: (i) There was no evidence for accumulation of putrescine against a concentration gradient in the neoplastic tissue (Figure 2 ). Indeed the tissue-medium ratio of the radioactivity after incubation with 10 or 80 LM putrescine was close to unity, whereas this ratio was always higher in the surrounding normal tissue. In some of the tumours the tissue-medium ratio was somewhat higher than unity, indicating that some active uptake could have taken place. An alternative explanation for this phenomenon is that some putrescine became bound to cellular components after entering the cell. Table I (ii) The requirement of energy for a process to take place can be verified by incubating the tissue at a low temperature. Although the rate of accumulation was slightly higher in lung tumour slices upon incubation at 37°C in comparison to incubation at 4°C, in both instances the accumulation was very low. The slightly greater uptake at 37°C can be explained by the enhancement of passive diffusion or by non-specific binding.
(iii) No evidence for saturation with increasing substrate concentration was found in the tumoral tissue. (iv) The absence of any inhibition of putrescine uptake in tumoral tissue by cystamine, another substrate of the pulmonary polyamine-uptake system (Lewis et al., 1989; Hoet et al., 1993) , provided further evidence for the lack of a carrier-mediated uptake system for putrescine in the tumoral tissue. Our results thus indicate that there was no active uptake of putrescine in the tumoral tissue investigated. There was one possible exception: the tumoral tissue of patient 16 clearly accumulated putrescine (although the levels were still lower than in the surrounding normal parenchyma). This tumour was a 4cm, large solid adenocarcinoma, with bronchiolar epithelium included in between tumour nests, which did not exhibit histopathological signs of high proliferative activity; the peritumoural tissue appeared normal but compressed. On the basis of the autoradiography, the accumulation in this sample was as a result of accumulation in all the different compartments of the tissue: the vascular tissue, the cells in the connective tissue and the neoplastic cells. Because of the general labelling, which was not seen in any other sample of either healthy or tumoral tissue, one cannot conclude that the tumour itself specifically accumulated putrescine. We have, however, no explanation for the general non-specific accumulation of putrescine in this tissue, except to hypothesise that this was perhaps a particularly rapidly growing tumour.
The polyamines (putrescine, spermidine, spermine) are ubiquitous amines that have been intensively studied in relation to cellular growth and proliferation, more specifically in relation to neoplastic growth and cell differentiation (Pegg, 1988) . The polyamine content in cells is usually regulated by
de novo synthesis and interconversion (Pegg et al., 1982 (Moulinoux et al., 1989a, b) . Deprivation of polyamines has been shown to inhibit tumour growth in mice (Sarhan et al., 1992) and the uptake of putrescine has been shown to be cell-cycle dependent in rat hepatocytes . The structure of the polyamine uptake system has not been elucidated, although a polyamine transport system has been recently isolated from Escherichia coli Kashiwagi et al., 1991) .
From an oncological point of view, the absence of a high polyamine accumulation in the tumours studied here is perhaps not surprising, since these solid tumours are not usually considered to proliferate rapidly. However, we had anticipated that at least some tumours would still bear this characteristic of their cells of origin, i.e. the alveolar or bronchiolar epithelium. Type II pneumocytes and Clara cells are stem cells of the lung epithelium (Breeze and Turk, 1984) . These dividing cells, or the precursors of these cells, are presumed to undergo neoplastic conversion to give rise to adenocarcinomas or bronchioloalveolar carcinomas in mice (Thaete and Malkinson, 1990) . In a recent report, Ten Have-Opbroek et al. (1994) suggested an oncofetal concept of bronchogenic carcinoma development. They hypothesised that a local retrodifferentiation of the bronchial epithelium, results in undifferentiated primordial-like cells, which in turn give rise to three possible tumour cell lines: alveolar (type II cell), bronchial and primordial.
The histogenesis of tumours is often derived from immunohistochemically staining of typical proteins or enzymes (Ten Have-Opbroek et al., 1990; Malkinson, 1991) . Our data, however, show that if human type II pneumocytes or Clara cells are the stem cells of the more common pulmonary epithelial tumours, they lose their ability or propensity to accumulate polyamines during the neoplastic transformation. We did not have the opportunity to study bronchioloalveolar tumours, which only rarely undergo surgical treatment. The same applies to small-cell lung tumours, which, however, have a different cellular origin anyway.
Further characterisation of the polyamine uptake in human pulmonary cancers, with e.g. coincubation with polyamine synthesis inhibitors, such as a-difluoromethylornithine (DFMO), which can strongly induce uptake (Janne et al., 1981 (Janne et al., , 1991 , were not performed because of the initial negative results and the expected technical difficulties. During the present study it was found that slices from tumours were more fragile than those from healthy human lung tissue; these slices often broke into numerous fragments, which hindered the recovery of the tissue after incubation. To compensate for the incomplete recovery of the tumoral tissue, the weight of the tissue was measured after the incubation. The viability of the neoplastic tissue may be limited by the dense cellular structure of the tumour which can possibly impair the diffusion of nutrients. A possible alternative would be to derive cell cultures from these tumours.
The absence of polyamine uptake in common lung cancers has its repercussions for the treatment or diagnosis of these conditions. The lack of an active polyamine uptake system implies that anti-cancer drugs that enter the cell via the polyamine uptake system, such as MGBG [methylglyxoxylbis(guanyl-hydrazone)] (Williams-Ashman and Seidenfeld, 1986; Pegg, 1988; Janne et al., 1991) and Diam 3 (Khan et al., 1991), will not be specifically transported into the tumour cells. Another consequence of the lack of substantial polyamine uptake in any of the examined lung neoplasms is that the uptake of a polyamine-like molecule cannot be used as a tool for the diagnosis or differential diagnosis of a particular type of lung cancer.
In conclusion, we have shown that the examined neoplastic lung tissue does not accumulate exogenous putrescine, in contrast to the surrounding pulmonary tissue. The absence of an active uptake system for polyamines was surprising, especially for the adenocarcinomas, considering the fact that their presumed progenitor cells, type II pneumocytes possess an active polyamine-uptake system.
